WestChina-Frontier PharmaTech Selects PDS Pathology Data Systems Ltd for Preclinical Data Management in Chengdu, China

Share Article

Preclinical software provider, PDS Pathology Data Systems Ltd., developer of the PathData, ToxData and ReproData Systems, was selected to be the data capture and reporting tool to be used by WestChina-Frontier PharmaTech at their AAALAC International accredited and GLP-compliant 80,000sf facility, also known as the National Chengdu Center for Safety Evaluation of Drugs (NCCSED) in Chengdu, PRC.

Frontier Training Class

The system is very functional and user-friendly, requiring minimal training and is supported by a world-class team. We selected PDS after extensive consultation with our clients, industry experts and in-depth familiarization of the software tools PDS offers. We are quite happy with our choice.

PDS Pathology Data Systems Ltd recently welcomed WestChina-Frontier PharmaTech, along with their Maryland-based partner, Frontier BioSciences, Inc. into their family of well-satisfied customers.

"It is a pleasure to have WestChina-Frontier PharmaTech and Frontier BioSciences, Inc. join us. The rigorous evaluation process they conducted is testament to the quality that goes into all the work they do," said Reto Aerni, Technical Director of PDS. Aerni went on to say, "We were most impressed with all of the staff that were trained on our software and can see how they will be able to leverage the efficiencies our software tools provide to help position them even further as quality leaders in preclinical studies in China."

Dr. Li Wang, CEO and Director of WestChina-Frontier PharmaTech commented, "We are committed to continuously improving our accuracy and efficiency. As such, the implementation of the PDS ToxData, PathData and ReproData Systems will only elevate our level of performance and ensure efficient delivery of data to our sponsors."

PDS provides a secure hosted GLP-Certified environment and maintains the GLP applications in a validated state. "The system is very functional and user-friendly, requiring minimal training and is supported by a world-class team. We selected PDS after extensive consultation with our clients, industry experts and in-depth familiarization of the software tools PDS offers. We are quite happy with our choice." remarked Dr. He Jiang, CSO of WestChina-Frontier PharmaTech and CEO of Frontier BioSciences-China.

About PDS Pathology Data Systems, Ltd-- PDS has a twenty-eight year history of providing preclinical software solutions to a very well-satisfied user base. With worldwide headquarters in Basel, Switzerland and New Jersey offices for North America user training, sales and support, PDS provides a full product suite of software solutions through its integrated and modular systems, PathData for post mortem activities, ToxData for general toxicology and clinical pathology and ReproData for reproductive and teratology studies.

PDS software is used by seven of the top ten pharmaceutical companies in the world and a user base from North America, Europe, China and Japan of small working groups to global multi-site organizations. Because it is a very flexible and multilingual system that is not dependent on any third-party applications, the PDS Software Suite it is ideally suited for a wide variety of users.

About Frontier BioSciences and WestChina-Frontier PharmaTech Co. Ltd.-- Frontier BioSciences, Inc. is a Maryland-based company that partners with WestChina-Frontier PharmaTech Co. Ltd. in Chengdu, China, providing a full spectrum of drug discovery and development resources to biotechnology and pharmaceutical industries in the scientific disciplines of GLP-compliant toxicology, developmental and reproductive toxicology, pharmacology, genetic toxicology, pathology, analytical chemistry and international regulatory guidance.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Arthur Karakos, CEO

Beth Wong, VP
Visit website